Fusion Pharmaceuticals Announces First Quarter 2023 Financial Results and Clinical Program Updates ...Middle East

FPI-2265 (Ac-PSMA I&T) program enrolling patients and on track for Q1 2024 update Preliminary Phase 1 data for FPI-1434 expected to be reported at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting Clinical progress across TAT pipeline continues; first patient...

Hence then, the article about fusion pharmaceuticals announces first quarter 2023 financial results and clinical program updates was published today ( Thursday 11/05/2023 - 02:21 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Fusion Pharmaceuticals Announces First Quarter 2023 Financial Results and Clinical Program Updates )

Also on site :

• Quote of the Day: Dr. Ruth Westheimer Believed True Happiness Begins With Taking Charge of Your Own Life
• Walmart's 'Super Cute' Half Moon Shoulder Bag Brings the Cow Print Trend to Your Wardrobe for Just $20
• James Murdoch may have reaped as much as $7.5 billion from his pre-IPO investment in Elon Musk’s SpaceX